CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...
Bittensor (TAO) fell about 7% in the last 24 hours even as most top altcoins climbed. Analysts say a breakout could p...
Alphabet plans nearly $185B in capital spending for 2026, mostly on data centers. This article highlights a crucial m...
U.S. stocks attempt to regain momentum on June 24, 2026, as investors digest fresh earnings and AI demand signals. Th...
A flashy video claiming Oprah endorses a magic cure can derail your budget in minutes. This guide explains how these ...
Bitcoin climbs back above $60,000 as July trading begins, while XRP-backed OUSD draws attention away from Circle USDC...
EDX Markets secures a $76 million Series C from SBI Holdings, marking a rare instance of a single investor backing an...
Analogs chip stocks rebound as demand stabilizes and inventories tighten, signaling a cycle turn for the semiconducto...
A federal case tied a Florida billing company to $64 million in Medicare brace claims linked to a Rock Island nursing...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
A cruise stock jumps as an activist investor takes a stake, signaling potential governance shifts. This article break...